Clinical Trial: A Study to Evaluate the Safety,Tolerability,Pharmacokinetics and Pharmacodynamics of Cenerimod in Adult Chinese Participants With Moderate-to-severe Systemic Lupus Erythematosus (SLE)

U.S., Dec. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07266090) titled 'A Study to Evaluate the Safety,Tolerability,Pharmacokinetics and Pharmacodynamics of Cenerimod in Adult Chinese Participants With Moderate-to-severe Systemic Lupus Erythematosus (SLE)' on Nov. 17.

Brief Summary: The goal of this clinical trial is to learn about the safety, how the body processes the drug, and its effects of a drug called cenerimod in adult Chinese participants (aged 18-75) with moderate to severe Systemic Lupus Erythematosus (SLE) who are already receiving standard background therapy.

The main questions it aims to answer are:

* What is the safety and tolerability of a daily 4 mg dose of cenerimod in Chinese partici...